ANNA MARIA CLELIA GALLOTTI

Dr. ANNA MARIA CLELIA GALLOTTI

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in European Journal of Radiology
Verified
Journal Article
Closed access
Ioan SporeaIoan Sporea
Ioan Sporea
SBSimona Bota
Simona Bota
MPMarkus Peck-Radosavljevic
Markus Peck-Radosavljevic
Roxana SirliRoxana Sirli
Roxana Sirli
HTHironori Tanaka
Hironori Tanaka
MDMirela Danila
Mirela Danila

1 July 2010 in American Journal of Roentgenology
Verified
Journal Article
Closed access
Mirko D'OnofrioMirko D'Onofrio
Mirko D'Onofrio
AGANNA MARIA CLELIA GALLOTTI
ANNA MARIA CLELIA GALLOTTI
RMRoberto Pozzi Mucelli
Roberto Pozzi Mucelli
OBJECTIVE. The purpose of this study was to describe the most reliable measurement procedure for acoustic radiation force impulse technology and to define the normal wave velocity values in a healthy liver.SUBJECTS AND METHODS. Twenty healthy volunteers underwent acoustic radiation force impulse imaging tissue quantification and were enrolled in this prospective study. All patients were examined by two independent operators at the same time. Twenty-four measurements per subject were obtained. Intraoperator and interoperator evaluations were performed. Statistical comparison of all mean data was performed with Student's t test. A value of p < 0.05 was considered significant. A comparative analysis was performed, and interclass correlation coefficients were calculated.RESULTS. The operators obtained 960 measurements. A statistically significant difference was found between the mean shear wave velocity values obtained by one operator deep in the right lobe of the liver and the values obtained on the surface ...

1 August 2014 in Pancreas
Verified
Journal Article
Closed access
SRSandro Rossi
Sandro Rossi
FVFrancesca Torello Viera
Francesca Torello Viera
GGGiorgia Ghittoni
Giorgia Ghittoni
LCLorenzo Cobianchi
Lorenzo Cobianchi
LRLaura Lavinia Rosa
Laura Lavinia Rosa
VRValentina Ravetta
Valentina Ravetta
Objective This study aimed to assess the feasibility, safety, and efficacy of radiofrequency ablation (RFA) of pancreatic neuroendocrine tumors (PNETs). Methods We performed RFA on 10 patients (7 women) aged 38 to 75 years with histologically diagnosed PNETs (secreting in 3 cases) who could not or would not undergo surgical resection. Tumor nodules (diameter, 0.9-2.9 cm; mean [SD], 1.6 [0.5] cm) were located in the head (n = 7) or body (n = 3) of the pancreas. Ultrasound-guided RFA was performed percutaneously (n = 7), endoscopically (n = 1), or intraoperatively (n = 2) using commercially available equipment. Complete ablation was defined as absence of enhancing tissue at the tumor site on contrast-enhanced imaging studies and normalization of previously elevated serum hormone levels. Results Complete ablation was achieved with 1 (n = 9) or 2 (n = 1) RFA procedures. All neuroendocrine syndromes regressed within 24 hours of treatment. No recurrences were observed during follow-up (range, 12–60 months; median [SD], 34 [14] months). No deaths occurred. Major complications included acute pancreatitis in 3 patients, 2 of whom developed pancreatic fluid collections that were successfully managed with ultrasound-guided drainage and endoscopy. Conclusions Radiofrequency ablation is a feasible, safe, and effective option for patients with small PNETs who cannot or do not want to undergo surgical resection.

1 April 2012 in European Journal of Radiology
Verified
Journal Article
Closed access
Mirko D'OnofrioMirko D'Onofrio
Mirko D'Onofrio
EBEmilio Barbi
Emilio Barbi
CDChristoph F. Dietrich
Christoph F. Dietrich
MKMasayuki Kitano
Masayuki Kitano
KNKazushi Numata
Kazushi Numata
RMRoberto Pozzi Mucelli
Roberto Pozzi Mucelli

1 September 2013 in Digestive and Liver Disease
Verified
Journal Article
Closed access
SBSimona Bota
Simona Bota
ISIoan Sporea
Ioan Sporea
MPMarkus Peck-Radosavljevic
Markus Peck-Radosavljevic
Roxana SirliRoxana Sirli
Roxana Sirli
HTHironori Tanaka
Hironori Tanaka
MDMirela Danila
Mirela Danila

1 February 2013 in American Journal of Roentgenology
Verified
Journal Article
Closed access
AGANNA MARIA CLELIA GALLOTTI
ANNA MARIA CLELIA GALLOTTI
RJRocio Perez Johnston
Rocio Perez Johnston
Pietro Andrea BonaffiniPietro Andrea Bonaffini
Pietro Andrea Bonaffini
TIThun Ingkakul
Thun Ingkakul
VDVikram Deshpande
Vikram Deshpande
DSDushyant V. Sahani
Dushyant V. Sahani
OBJECTIVE. The objective of our study was to evaluate the MDCT features of incidentally detected neuroendocrine tumors (NETs) of the pancreas, identify features that can predict tumor biology or aggressiveness and long-term outcome, and determine the incidence of “nonbenign” behavior. MATERIALS AND METHODS. In this retrospective study, 60 histologically verified pancreatic NETs incidentally detected with contrast-enhanced MDCT were included. Various MDCT features such as size, morphology, enhancement, and presence of calcifications were evaluated and were correlated with tumor biology on histopathology. The sensitivity, specificity, predictive values, and accuracy were calculated for MDCT features in predicting nonbenign biology and risk of recurrence. RESULTS. A total of 32 of 60 (53%) NETs were nonbenign: most were large (mean, 29.1 mm) with a solid or complex pattern. NET size of 3 cm or larger yielded a positive predictive value of 61% for nonbenign tumors and 100% when calcification was present. In 1...